Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis: A Phase II Randomized Placebo Controlled Trial

NCT03450083 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT03450083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03450083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benralizumab Effect on Severe Chronic Rhinosinusitis With Eosinophilic Polyposis: A Phase II Randomized Placebo Controlled Trial
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2017
Completion date
February 1, 2020
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis (diagnosis), eosinophilia, nasal polyps